Dow Jones Newswires: Celltrion shares rally in South Korea after EU OKs marketing of its COVID-19 treatment
Celltrion Inc.'s shares rallied Monday after the European Commission granted the South Korean biotech firm approval to market its COVID-19 antibody treatment.
from MarketWatch.com - Top Stories https://ift.tt/2YOXnJW
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/2YOXnJW
via IFTTT
Kommentare
Kommentar veröffentlichen